[41] Mice lacking SOD1 develop a wide range of pathologies, including hepatocellular carcinoma, [42] an acceleration of age-related muscle mass loss, [43] an earlier incidence of cataracts, and a reduced lifespan
you have any questions or concerns
No dramatic visible change yet, and thats normal
Rajizadeh MA, Bejeshk MA, Doustimotlagh AH, Najafipour H, Eftekhari M, Mahmoodi M, Azizi M, Rostamabadi F, Pourghadamyari H
Its the only long-acting amylin analog in late-stage trials, which means it doesnt compete on the same biological turf as GLP-1 drugs
This is research-planning context, not a personal dosing recommendation